Delivery Order SPE2DB20D2001-SPE2DB23FM56H
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,574.32 contract is for the supply of 4,567,873,866 units of Diovan HCT 160-25 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle with a performance period...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,454 units of Diovan HCT 160-12.5 mg tablets in 90-count packages, with a ceiling value of $2,825.59. The contract has an ultimate completion date of April 29, 2025 and was awarded on April 28, 2025. This delivery order is part of a larger Indefinite Delivery...
- This is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp (a major pharmaceutical distributor and healthcare solutions provider) by the Defense Logistics Agency (DLA) to provide 4,561,391,525 units of Diovan HCT 160-25 mg tablets. The $5,845.12 contract has a completion date of July 3, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to supply a broad range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,589,059 tablets of Diovan HCT 160-25 mg. The contract has a potential value of $9,096.15 and a completion date of February 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of...
- This federal contract award, valued at $3,857.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Diovan HCT 160-12.5 mg tablets, a cardiovascular medication. This is a firm-fixed-price delivery order contract, with an ultimate completion date of October 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,914.69, is for the delivery of Diovan HCT 80-12.5 mg tablets over a period ending on April 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and is...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,124.20, is for the delivery of Diovan HCT 160-12.5 mg tablets. It is a firm fixed-price delivery order contract with a completion date of January 25, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,856.69, is for the delivery of Diovan HCT 160-12.5 mg tablets. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $31,914.40 and is for the delivery of Diovan HCT 160-25 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of October 23, 2023. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,155.63, is for the delivery of Diovan HCT 160-12.5 mg tablets. The contract is not set aside and is a firm fixed-price delivery order. It has an ultimate completion date of April 22, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB23FM56HDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,082,757 units of Diovan HCT 160-12.5 mg tablets, a cardiovascular medication, for a firm fixed price of $12,979.35. The contract has a period of performance through May 31, 2023 and was awarded on May 30, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 5/30/23 |